Osgood, C.P. , Dujovny, M., Faille, R., et al.: Early scanning electron microscopic evaluation of microvascular maneuvers. Angiology, 27: 96-105, 1976.
2.
Buncke, H.J. , MacLean, D.H., George, P.T., et al.: Thumb replacement: Great toe transplantation by microvascular anastomosis. Br. J. Plast. Surg., 26: 194-201, 1973.
Herbsman, H. , Lafer, D.J., Shartan, G.W.: Successful replantation of an amputated hand. Ann. Surg., 163: 137-143, 1966.
6.
Cohen, B.E., May, J.W., Daly, J.S.F., et al.: Successful clinical replantation of an amputated penis by microneurovascular repair: Case report. Plast. Reconstr. Surg., 59: 276-280, 1977.
7.
Sundt, T.M., Siekert, R.G., Piepgras, D.G., et al.: Bypass surgery for vascular disease of the carotid system. Mayo Clin. Proc., 51: 677-692, 1976.
8.
Didisheim, P. , Owen, C.A.: Effect of dipyridamole (Persantine) and its derivates on thrombosis and platelet function. Thrombos. Diath. Haemorrh., 41-43: 267-275, 1970-1971 (Suppl.).
9.
Rosenbaum, T.J. , Sundt, T.M.: Thrombus formation and endothelial alterations in microarterial anastomoses. J. Neurosurg., 47: 430-441, 1977.
10.
Nishizawa, E.E.: Flurbiprofen, a new potent inhibitor of platelet aggregation. Stroke, 5: 298, 1974.
11.
Acland, R.: Prevention of thrombosis in microvascular surgery by the use of magnesium sulfate. Br. J. Plast. Surg., 25: 292-299, 1972.
12.
Gertz, S.D. , Rennels, M.L., Nelson, E.: Endothelial cell ischemic injury: Protective effect of heparin or aspirin assessed by scanning electron microscopy. Stroke, 6: 357-360, 1975.
13.
Kelton, J.G. , Hirsh" J., Carter, C.J., et al.: Thrombogenic effects of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2like activity. J. Clin. Invest.,62: 892-895, 1978.
14.
Arfors, K.E., Hint, H.C., Dhall, D.P., et al.: Counteraction of platelet activity at sites of laser-induced endothelial trauma. Br. Med. J., 4: 430-431, 1968.
Piepgras, D.G. , Sundt, T.M., Didisheim, P.: Effect of aspirin on anticoagulants inhibitors of platelet aggregation on thrombotic occulsion of endarterectomized cat carotid arteries. Stroke, 7: 248-254, 1976.
17.
Dyken, M.L. , Campbell, R.L., Muller, J., et al.: Effect of aspirin on experimentally induced arterial thrombosis during the healing phase. Stroke , 4: 387-389, 1973.
18.
Danese, C.A. , Haimov, M.: Inhibition of experimental arterial thrombosis in dog with platelet deaggregating agents. Surgery, 70: 927-934, 1970.
19.
Oblath, R.W. , Buckley, F.O., Green, R.M., et al.: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery, 84: 37-44, 1978.
Sawyer, P.N. , Stanczewski, B., Pomerance, A., et al.: Utility of anticoagulant drugs in vascular thrombosis: Electron microscopic and biophysical study. Surgery, 74: 263-275, 1973.
22.
Folts, J.D. , Crowell, E.B., Rowe, G.G.: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation, 54: 365-370, 1976.
23.
Mason, R.G. , Wolf, R.H., Zucker, W.H., et al.: Effects of anti-thrombotic agents evaluated in a non-human primate. Vascular shunt model. Am. J. Pathol., 83: 557-564, 1976.
24.
Harker, L.A. : Thromboembolic animal models and the in vivo evaluation of antithrombotic agents. Stroke, 5: 299, 1974.
25.
Barnett, H.J. : Platelet and coagulation junction in relation to thromboembolic stroke, in Advances in Neurology. Vol. 16. Edited by R.A. Thompson, J.R. Green.New York, Raven Press, 1977, pp. 45-69.
26.
Weiss, H.J. : Antiplatelet therapy. N. Engl. J. Med., 298: 1344-1347, 1978.
27.
Szilagyi, D.E. , Whitcomb, J.G., Schenker, W., et al.: The laws of fluid flow and arterial grafting. Surgery, 47: 55-73, 1960.
28.
O'Brien, B.M. : Microvascular Reconstructive Surgery. Edinburgh, London, and New York , Churchill, Livingstone, 1977, pp. 46-48, 71-76.
29.
Jorgensen, L., Rowsell, H.C., Hovig, T., et al.: Resolution and organization of platelet-rich neural thrombi in carotid arteries of swine. Am. J. Pathol. , 51: 681-719, 1967
30.
Elcock, H.W. , Frederickson, J.M.: The effect of heparin on thrombosis at microvenous anastomotic site. Arch. Otolaryngol., 95: 68-71, 1972.
31.
Bounameaux, Y., Cauwenberge, H.V.: Action de la cortisone del'A.C.T.H. et salicylate de soude sur les thrombocytes et la coagulation sanguine. Sang, 25: 889-899, 1954.
32.
Weiss, H.J. , Aledort, L.M.: Impaired platelet connective tissue reaction in man after aspirin ingestion. Lancet, 2: 495-497, 1967.
33.
O'Brien, J.R. : Effects of salicylates on human platelets. Lancet, 1: 779-783, 1968.
34.
Smith, J.B. , Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol.), 231: 235-237, 1971.
35.
Samuelson, B.: The role of prostaglandin endoperoxides and thromboxanes in human platelets, in Prostaglandins in Hematology. Edited by M.J. Silver, J.B. Smith, J.J. Kocsis. New York, Spectrum, 1977, pp. 1-10.
36.
Moncada, S. , Korbut, R.: Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by protentrating endogenous protacyclin . Lancet, 1: 1286-1289, 1978 .
37.
Emmons, P.R. , Harrison, M.J.G., Honour, A.J., et al.: Effects of dipyridamole on human platelet behavior. Lancet, 2: 603-606, 1965.
38.
Browse, N.L. , Hall, J.H.: Effects of dipyridamole on the incidence of clinically detectable deep vein thrombosis. Lancet, 2: 718-721, 1969.
39.
Rogers, P.H. , Sherry, S.: Current status of anti-thrombotic therapy in cardiovascular disease. Prog. Cardiovasc. Dis., 19: 235-253, 1976.
40.
Nishizawa, E.E., Miller, W.L., Gorman, R.R., et al.: Prostaglandin D2 as a potential antithrombotic agent. Prostaglandin, 9: 109-121, 1975.
41.
Smith, J.B. , Silver, M.J., Ingerman, C.M., et al.: Prostaglandin D2 inhibits the aggregation of human platelets. Thromb. Res., 5: 291-299, 1974.
42.
Mills, D.C.B. , Macfarland, D.E.: Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb. Res., 5: 401-412, 1974.
